Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Micron Pure is a private U.S. environmental health and medical air-cleaning company developing and licensing ozone-based air and surface sanitation technology. Its core platform uses ozone together with a catalyst to inactivate airborne pathogens while the company states that zero ozone is released into occupied spaces. The company markets and supports the CerroZone family of air purification devices and positions the technology for hospitals, schools, businesses, transportation, military housing, and other indoor environments. Publicly available materials indicate Micron Pure was founded in 2020 and has operations tied to the Kansas City and St. Louis regions. The business appears to be a health-adjacent medical device and indoor air quality company rather than a therapeutics-focused biotech or pharmaceutical developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Micron Pure.